Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Vikas Veer: Exploring Sickle Cell Anemia at the Molecular Level
Sep 18, 2026, 05:08

Vikas Veer: Exploring Sickle Cell Anemia at the Molecular Level

Vikas Veer, Chief Executive Officer at dumblearner.com, shared a post on LinkedIn:

“Sickle Cell Anemia at the molecular level: a single amino acid substitution (glutamic acid – valine) alters hemoglobin’s polymerization behavior, causing red blood cells to deform into a rigid sickle shape once deoxygenated.

The downstream clinical picture is well known to most clinicians – vaso-occlusive pain episodes, acute chest syndrome, stroke risk in pediatric patients, and early splenic autoinfarction – but the underlying biomechanics are worth revisiting, especially for patient education purposes.

This short breaks down the pathophysiology, inheritance pattern (autosomal recessive, nearly 25% risk with two carrier parents), U.S. prevalence (nearly 1 in 400 African American newborns), and current management options including hydroxyurea and bone marrow transplant.

Useful for anyone building patient-facing education content or explaining genetic blood disorders to non-clinical audiences.”

Proceed to the video attached to the post.

Stay updated with Hemostasis Today.